MAGE-A3 was more commonly detected in metastatic (76%) vs primary (36%) melanoma lesions [7], and in relapsed (77%) vs newly diagnosed, untreated (36%) multiple myeloma cases [11]. The gene discussed is MAGEA3; the disease is plasma cell myeloma.